Value of the <scp>HFA‐PEFF</scp> and <scp> H <sub>2</sub> FPEF </scp> scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis
Daniela Tomasoni(University of Brescia), Marco Metra(Vita-Salute San Raffaele University), Carlo Lombardi(Fondazione Poliambulanza Istituto Ospedaliero), Michele Emdin(Scuola Superiore Sant'Anna), Gianfranco Sinagra(Società Italiana di Cardiologia), Giuseppe Vergaro(Scuola Superiore Sant'Anna), Giorgia Panichella(Scuola Superiore Sant'Anna), Dario Cani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Anas Khalil(Scuola Superiore Sant'Anna), Marianna Adamo(Surgical Specialties (Canada)), Maria Franzini(University of Pisa), Aldostefano Porcari(Azienda Sanitaria Universitaria Integrata di Trieste), Marco Merlo(Ospedale Policlinico San Martino), Alberto Aimo(Scuola Superiore Sant'Anna), Maddalena Rossi(University of Trieste), Matilde Nardi(Surgical Specialties (Canada)), Edoardo Pancaldi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Maria Giulia Bellicini(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Claudio Rapezzi(University of Ferrara)
Cited by 43
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k